A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus
Study sponsor: Cocrystal Pharma, Inc. · COCP
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-09-14Actual
Enrollment · participants32Actual
Source updated2026-10-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.